PAG
CVAC

Private Advisor Group’s CureVac CVAC Stock Holding History

Private Advisor Group’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,236
Closed -$30.1K – 2330
2024
Q3 		$30.1K Buy
+10,236
New +$33.7K ﹤0.01% 2364
2021
Q2 		– Sell
-5,150
Closed -$471K – 1991
2021
Q1 		$471K Buy
5,150
+225
+5% +$21.8K ﹤0.01% 1334
2020
Q4 		$399K Buy
+4,925
New +$377K ﹤0.01% 1333

Other funds holding CVAC

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Private Advisor Group's CVAC Position: Q4 2024 in Review

Private Advisor Group sold out of CureVac (CVAC) in Q4 2024, closing a stake of 10,236 shares — an estimated $30.1K sold.

Private Advisor Group first reported a position in CVAC in Q4 2020 and held it in 3 quarters. The position peaked at $471K in Q1 2021. 75 funds tracked by Wall St. Rank hold CVAC as of Q4 2024.

  • Private Advisor Group reported no remaining CureVac position as of Q4 2024 after selling out during the quarter.
  • Private Advisor Group sold 10,236 CureVac shares in Q4 2024, an estimated $30.1K.
  • Private Advisor Group first reported a position in CureVac in Q4 2020 and held it in 3 quarters.
  • Private Advisor Group's CureVac position peaked at $471K in Q1 2021.
  • 75 funds tracked by Wall St. Rank held CureVac as of Q4 2024.

Based on Private Advisor Group's 13F filing for Q4 2024, filed 3 Feb 2025.